Literature DB >> 1350301

Fimbria-mediated adherence and hemagglutination of Haemophilus influenzae.

S M van Ham1, L van Alphen, F R Mooi.   

Abstract

The gram-negative bacterium Haemophilus influenzae expresses morphologically and functionally distinct types of fimbriae, of which the LKP fimbriae mediate hemagglutination and adherence to human epithelial cells but hamper mucosal invasion. Therefore, the both in vivo and in vitro observed fimbrial phase variation may contribute to the pathogenesis of the infection. The existence of greater than 14 LKP serotypes hampers vaccine development based on fimbriae, since a monovalent fimbria vaccine confers protection against only the homologous strain. Cloning of the fimbrial genes in Escherichia coli results in the expression of morphologically intact fimbriae. Analysis of the cloned DNA indicates that a fimbrial gene cluster is necessary for formation of complete fimbriae and for fimbria-mediated adherence. The gene encoding the subunit is highly conserved among H. influenzae and belongs to the family of E. coli fimbriae. The phase variation is transcriptionally regulated by variation of the length of the reiterated sequence that forms the promoter region of the subunit gene.

Entities:  

Mesh:

Year:  1992        PMID: 1350301     DOI: 10.1093/infdis/165-supplement_1-s97

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Maximum depth sequencing reveals an ON/OFF replication slippage switch and apparent in vivo selection for bifidobacterial pilus expression.

Authors:  Christophe Penno; Mary O'Connell Motherway; Yuan Fu; Virag Sharma; Fiona Crispie; Paul D Cotter; Benoit Houeix; Lokesh Joshi; Francesca Bottacini; Aoife O'Dwyer; Gary Loughran; John F Atkins; Douwe van Sinderen
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  High-molecular-weight proteins of nontypeable Haemophilus influenzae mediate bacterial adhesion to cellular proteoglycans.

Authors:  G J Noel; D C Love; D M Mosser
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.